Anti-cancer management of head and neck cancers and oral microbiome—what can we clinically obtain? - Publikacja - MOST Wiedzy

Twoje konto

zaloguj

Wyszukiwarka

Anti-cancer management of head and neck cancers and oral microbiome—what can we clinically obtain?

Abstrakt

Head and neck squamous cell carcinoma (HNSCC) exhibits significant genetic heterogeneity and primarily concerns the oral cavity and oropharynx. These cancers occur more frequently in men with a 5-year survival rate below 50%. Major risk factors include human papilloma virus (HPV) (notably type 16), Epstein–Barr virus, tobacco, alcohol, and poor oral hygiene with approximately 4.5% of global cancers linked to HPV. Notably, differences in the microbiome between healthy individuals and patients with head and neck cancers (HNCs) have been identified. Recent studies highlight the significance of certain oral microbes in risk assessment and the potential of the microbiome as a biomarker for HNCs. Additionally, role of the microbiome in metastasis has been acknowledged. Treatment for HNCs includes local methods, such as surgery and radiotherapy, and systemic approaches, such as immunotherapy. Numerous side effects accompany these treatments. Emerging research suggests the beneficial role of preoperative immunonutrition and probiotics in patient outcomes, emphasizing the influence of the microbiome on treatment efficacy. This review explores the reciprocal effects of HNC treatment and the gut microbiome using radiotherapy, brachytherapy, surgery, immunotherapy, and chemotherapy.

Cytowania

  • 3

    CrossRef

  • 0

    Web of Science

  • 3

    Scopus

Autorzy (6)

Cytuj jako

Pełna treść

pobierz publikację
pobrano 12 razy
Wersja publikacji
Accepted albo Published Version
DOI:
Cyfrowy identyfikator dokumentu elektronicznego (otwiera się w nowej karcie) 10.3389/fcimb.2024.1329057
Licencja
Creative Commons: CC-BY otwiera się w nowej karcie

Słowa kluczowe

Informacje szczegółowe

Kategoria:
Publikacja w czasopiśmie
Typ:
artykuły w czasopismach
Opublikowano w:
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY nr 14, strony 1 - 8,
ISSN: 2235-2988
Język:
angielski
Rok wydania:
2024
Opis bibliograficzny:
Makarewicz J., Kaźmierczak-Siedlecka K., Sobocki B. K., Dobrucki I. T., Kalinowski L., Stachowska E.: Anti-cancer management of head and neck cancers and oral microbiome—what can we clinically obtain?// FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY -Vol. 14, (2024),
DOI:
Cyfrowy identyfikator dokumentu elektronicznego (otwiera się w nowej karcie) 10.3389/fcimb.2024.1329057
Źródła finansowania:
  • This research was funded by the Polish Ministry of Education and Science, grants no. 10/E-389/SPUB/SP/2020 and ST 531 (01-50023/00004940 Medical University of Gdansk).
Weryfikacja:
Politechnika Gdańska

wyświetlono 1 razy

Publikacje, które mogą cię zainteresować

Molecular Profiling for Predictors of Radiosensitivity in Patients with Breast or Head-and-Neck Cancer

  • K. Drobin,
  • M. Marczyk,
  • M. Halle
  • + 11 autorów
2020

Nanotechnology meets radiobiology: Fullerenols and Metallofullerenols as nano-shields in radiotherapy

  • P. Kazmierska-grebowska,,
  • M. Jankowski,
  • E. Obrador
  • + 3 autorów
2025

EP-1817: Radiotherapy-related changes in serum proteome patterns of head and neck cancer patients

  • P. Widlak,
  • M. Pietrowska,
  • J. Polanska
  • + 6 autorów
2014

Insights into oral microbiome and colorectal cancer – on the way of searching new perspectives

  • A. Kudra,
  • D. Muszyński,
  • B. K. Sobocki
  • + 5 autorów
2023
Meta Tagi